MPO and cholesteatoma: For example, a study involving 21 patients with COM with cholesteatoma, 40 patients with COM without cholesteatoma, and 30 healthy controls found that serum MPO, 4-HNE, MDA, and NO levels were significantly higher, whereas TAC levels were significantly lower, in the COM groups than in the control group (p < 0.001 each).